HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Related articles in AJCN Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bosy-Westphal, A. Articles by Müller, M. J. Search for Related Content PubMed PubMed Citation Articles by Bosy-Westphal, A. Articles by Müller, M. J. Agricola Articles by Bosy-Westphal, A. Articles by Müller, M. J.

Determinants of hyperhomocysteinemia in patients with chronic liver disease and after orthotopic liver transplantation^1,2,3

¹ From the Institut für Humanernährung und Lebensmittelkunde (AB-W, MR, and MJM), the Klinik für Nuklearmedizin (NC), and the 1. Medizinische Klinik (HH), Universität Kiel, Kiel, Germany; Rehaklinik Föhrenkamp, Mölln, Germany (GO); and Krankenhaus Dessau (MP) and Klinikum Kröllwitz (EL and WF), Martin-Luther-Universität Halle, Halle, Germany.

Background: Homocysteine metabolism may be impaired in chronic liver disease, possibly contributing to fibrogenesis and disease complications.

Objective: The goal was to investigate the prevalence and determinants of basal and postprandial hyperhomocysteinemia in patients with chronic liver disease and after orthotopic liver transplantation (OLT).

Design: This was a cross-sectional study of 323 patients with chronic liver disease (93 with hepatitis, 8 with fatty liver, 168 with cirrhosis, and 54 after OLT) and 25 healthy control subjects. Portohepatovenous gradients of total homocysteine (tHcy) and methionine and postload methionine and tHcy kinetics before and after 10 d of supplementation with folate plus vitamin B-6 were investigated in subgroups.

Results: Basal hyperhomocysteinemia was observed in all patient groups (34% of patients with hepatitis, 50% with fatty liver, 54% with cirrhosis, and 52% after OLT). It was more frequently seen in patients with elevated plasma creatinine concentrations and at advanced stages of liver disease. Mean plasma folate was normal in patients with liver disease, but vitamin B-12 was elevated in cirrhosis and vitamin B-6 was low after OLT. There were significant negative associations between tHcy and folic acid or vitamin B-12 concentrations in control subjects and in patients with hepatitis and after OLT. No systematic association between portohepatovenous differences in tHcy and methionine concentrations was found. Cirrhosis was accompanied by impaired methionine clearance. After vitamin supplementation, the area under the tHcy curve improved in cirrhosis at nearly unchanged basal tHcy concentrations.

Conclusions: Basal hyperhomocysteinemia is seen in 50% of patients with cirrhosis and after OLT. Basal tHcy concentrations do not change significantly after supplementation with folate and vitamin B-6, but postprandial Hcy metabolism improves.

Key Words: Homocysteine • methionine load • hepatitis • liver cirrhosis • liver transplantation • folic acid • vitamin B-12 • vitamin B-6

Related articles in AJCN:

Methionine metabolism in liver diseases

James D Finkelstein
AJCN 2003 77: 1094-1095. [Full Text]  

This article has been cited by other articles:

				G Bianchi, G Marchesini, and M Zoli Hyperhomocysteinaemia and vascular disease in liver patients. Gut, June 1, 2006; 55(6): 896 - 896. [Full Text] [PDF]

				S. A. Craig Betaine in human nutrition Am. J. Clinical Nutrition, September 1, 2004; 80(3): 539 - 549. [Abstract] [Full Text] [PDF]

				J. D Finkelstein Methionine metabolism in liver diseases Am. J. Clinical Nutrition, May 1, 2003; 77(5): 1094 - 1095. [Full Text] [PDF]